Hirose Yoshinobu

ヒロセヨシノブ | Hirose Yoshinobu

Affiliation and department：

Research field (3)： Experimental pathology , Human pathology , Tumor diagnostics and therapeutics

Research keywords (5)： Colorectal cancer , Tumor metabolism , Obesity/nutrition and carcinogenesis , Premalignant lesion , Chemoprevention

Research theme for competitive and other funds (11)：

2022 - 2025 進行大腸癌における転移特異的な代謝表現型に関する研究
2019 - 2022 がん細胞ゼブラフィッシュ移植モデルによるアッセイ系の構築~膵癌克服への布石~
2018 - 2021 A Developing Diagnostic Method of Invasion Depth about Bladder Cancer, using a new Multi-Parametric MRI and applying it to a Therapeutic Strategy
2012 - 2015 Suppressive effects of PPARalpha agonist against pulmonary carcinogenesis in mice
2013 - 2015 Pathological evaluation for advanced colorectal cancer aiming at treatment proposal for molecular targeted drugs

Show all

Papers (321)：

Wataru Hamada, Nahoko Kato-Kogoe, Koji Yamanegi, Hirofumi Kanetake, Azumi Hirata, Tetsuya Terada, Yoshitaka Kurisu, Hidenori Une, Yoshinobu Hirose, Tohru Nakanishi, et al. Tetraspanin CD81 is expressed in human parotid cancer tissue and mediates cell proliferation. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology. 2024
Shota Fujii, Mitsuaki Ishida, Kazumasa Komura, Kazuki Nishimura, Takuya Tsujino, Tomohito Saito, Yohei Taniguchi, Tomohiro Murakawa, Haruhito Azuma, Yoshinobu Hirose. Expression of Preferentially Expressed Antigen in Melanoma, a Cancer/Testis Antigen, in Carcinoma In Situ of the Urinary Tract. Diagnostics (Basel, Switzerland). 2023. 13. 24
Kazumasa Komura, Kensuke Hirosuna, Satoshi Tokushige, Takuya Tsujino, Kazuki Nishimura, Mitsuaki Ishida, Takuo Hayashi, Ayako Ura, Takaya Ohno, Shogo Yamazaki, et al. The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer. Molecular Cancer. 2023. 22. 1
Ryo Kawata, Ichita Kinoshita, Tsuyoshi Jinnin, Masaaki Higashino, Tetsuya Terada, Yoshitaka Kurisu, Yoshinobu Hirose, Takeshi Tochizawa. Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma. International journal of clinical oncology. 2023
Yoshinobu Hirose, Kohei Taniguchi. Intratumoral metabolic heterogeneity of colorectal cancer. American Journal of Physiology-Cell Physiology. 2023

ｍore...

MISC (146)：

廣瀬善信. 善先生のがんなにそれ講座まずは相手を知らなあかんで(第4回). がん看護. 2022. 27. 7. 719-722
寺田哲也, 河田了, 東野正明, 栗栖義賢, 桑原宏子, 廣瀬善信. 【ANL Secondary Publication】耳下腺基底細胞腺癌術前診断における基底細胞腺腫との比較. 日本耳鼻咽喉科頭頸部外科学会会報. 2022. 125. 9. 1419-1420
小村和正, 吉見昭秀, 谷口高平, 小沼剛, 稲元輝生, 廣瀬善信, 東治人. FGFR muts/fusion-CD274/PD-L1のマルチオミクス解析最適化医療応用の可能性(The Association of FGFR Genetic Alternation with CD274/PD-L1 Profiling in Bladder Cancer). 日本癌学会総会記事. 2022. 81回. MS5-3
駒澤伸泰, 佐浦隆一, 金沢徹文, 瀧谷公隆, 廣瀬善信, 河田了, 寺崎文生, 中野隆史. ニューノーマルの医学教育に必要な'学友'と'正課外活動'の意義を考える新型コロナウイルス感染症パンデミックからの教訓. 大阪医科薬科大学医学会雑誌. 2022. 81. 1-2. 68-73
廣瀬善信. 善先生のがんなにそれ講座まずは相手を知らなあかんで(第3回). がん看護. 2022. 27. 6. 629-633

ｍore...

Education (2)：

Professional career (1)：

Work history (5)：

2021/04 - 現在 Osaka Medical and Pharmaceutical University Department of Pathology Professor
2013/08 - 2021/03 Osaka Medical College Department of Pathology Professor
2007/04 - 2013/07 Gifu University Hospital Division of Pathology Associate Professor
2004/04 - 2007/03 Gifu University Hospital Division of Pathology Associate Professor
1997/06 - 2004/03 Gifu University Hospital Department of Laboratory Medicine Assistant Professor

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page